×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Peter P. Pfreundschuh


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VYGRVoyager Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerFeb 21, 2024Sale$7.463,76428,079175,669Feb 22, 2024, 04:32 PM
VYGRVoyager Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerOct 03, 2023Sale$6.9913,56794,833149,433Oct 05, 2023, 04:41 PM
FREQFrequency Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerFeb 18, 2022Sale$3.881,4045,44310,469Feb 23, 2022, 04:38 PM
FREQFrequency Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerFeb 22, 2022Sale$3.531,5425,4428,927Feb 23, 2022, 04:38 PM
FREQFrequency Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerFeb 16, 2022Sale$4.431,2295,44313,169Feb 18, 2022, 04:14 PM
FREQFrequency Therapeutics, Inc.Peter P. PfreundschuhChief Financial OfficerFeb 17, 2022Sale$4.201,2965,44311,873Feb 18, 2022, 04:14 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerOct 15, 2020Option/RSU Exercise-4,917-12,805Oct 16, 2020, 03:41 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerOct 15, 2020Sale$21.772,40052,24811,829Oct 16, 2020, 03:41 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerSep 01, 2020Sale$22.8250911,6157,888Sep 01, 2020, 02:37 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerSep 01, 2020Option/RSU Exercise-1,042-8,397Sep 01, 2020, 02:37 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerJul 26, 2020Option/RSU Exercise-417-7,496Jul 28, 2020, 05:34 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerJul 27, 2020Sale$23.511413,3157,355Jul 28, 2020, 05:34 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerMay 20, 2020Option/RSU Exercise-1,041-7,437May 20, 2020, 04:44 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerMay 20, 2020Sale$25.073588,9757,079May 20, 2020, 04:44 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerApr 27, 2020Sale$24.351413,4336,396Apr 28, 2020, 01:51 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerApr 26, 2020Option/RSU Exercise-417-6,537Apr 28, 2020, 01:51 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerFeb 20, 2020Option/RSU Exercise-1,042-6,480Feb 24, 2020, 04:53 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerFeb 20, 2020Sale$29.6836010,6856,120Feb 24, 2020, 04:53 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerJan 26, 2020Option/RSU Exercise-1,666-5,105Jan 28, 2020, 05:15 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerJan 27, 2020Sale$29.2866719,5304,438Jan 28, 2020, 05:15 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerNov 20, 2019Option/RSU Exercise-1,042-3,793Nov 22, 2019, 01:29 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerNov 20, 2019Sale$28.4135410,0573,439Nov 22, 2019, 01:29 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerAug 20, 2019Option/RSU Exercise-4,167-4,167Aug 22, 2019, 01:31 PM
URGNUroGen Pharma Ltd.Peter P. PfreundschuhChief Financial OfficerAug 20, 2019Sale$33.071,41646,8272,751Aug 22, 2019, 01:31 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe